Amputation Risk in Type II Diabetes Mellitus Patients Treated with SGLT-2 Inhibitors: A Systematic Literature Review of Randomized Clinical Trials.
使用 SGLT-2 抑制劑治療的 II 型糖尿病患者截肢風險：隨機臨床試驗的系統文獻回顧。
Drug Res (Stuttg) 2024-08-02
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.
腎臟疾病和2型糖尿病患者使用鈉葡萄糖共同轉運蛋白2抑製劑的安全性：美國人口基礎的世代研究。
Clin J Am Soc Nephrol 2024-05-02
Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.
SGLT2抑制劑治療與骨髓炎風險：FAERS資料庫的藥物監察研究。
Front Pharmacol 2023-03-04
Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors <i>versus</i> DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients.
糖尿病患者使用SGLT2抑制劑相對於DPP4抑制劑或GLP-1激動劑的下肢截肢風險：200萬名患者的荟萃分析。
Ther Adv Drug Saf 2023-06-20
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study.
使用鈉葡萄糖共同轉運蛋白2抑制劑或葡萄糖樣肽-1受體激動劑與磺脲藥物在下肢截肢風險之比較：全國性群集研究。
Cardiovasc Diabetol 2023-11-22
Safety of sodium-glucose co-transporter-2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes.
二型糖尿病患者基準心血管疾病和利尿劑使用類別中，鈉葡萄糖共同轉運蛋白2抑製劑對截肢的安全性。
Diabetes Obes Metab 2023-10-11
Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials.
第二型糖尿病患者中不同鈉葡萄糖轉運蛋白2抑制劑的比較安全性：對隨機對照試驗的系統性回顧和網絡荟萃分析。
Front Endocrinol (Lausanne) 2023-09-15
Safety of sodium-glucose transporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes: a meta-analysis of cohort studies.
二型糖尿病患者使用鈉葡萄糖轉運蛋白2 (SGLT-2) 抑制劑的安全性：一項世代研究的荟萃分析。
Front Pharmacol 2023-11-01
Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study.
SGLT2 抑制劑降低糖尿病足患者住院心衰風險和截肢率，與胰高血糖素類治療相比：全國人口基礎研究。
Endocr Pract 2024-02-25
Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a Network Meta-analysis and Meta-regression.
SGLT-2 抑制劑導致的四肢截肢和骨折風險：網絡 Meta 分析和 Meta 迴歸。
Expert Opin Drug Saf 2024-07-05